New Zealand King Salmon Investments Limited logo

NZK 1H17 Interim Report

Earnings Results29 March 2017NZKConsumer Staples

New Zealand King Salmon
Investments Limited

and Subsidiaries

INTERIM

FINANCIAL

REPORT

FOR THE SIX MONTHS ENDED

31 DECEMBER 2016

CONTENTS
4

5

6

7

8

9

10

18

DIRECTORS’ REPORT

CORPORATE INFORMATION

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2016

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

REVIEW REPORT

3

INTERIM FINANCIAL REPORT

FINANCIAL PERFORMANCE
The six month period ending 31 December 2016 marks a new

milestone in the evolution of New Zealand King Salmon with the

successful Initial Public Offering (IPO) on the New Zealand and

Australian stock exchanges in October 2016. Through this process,

New Zealand King Salmon raised $30 million in new equity to

invest in production capacity and working capital to establish and

grow our new sea farms, and to carry out improvements in our

existing processing and aquaculture infrastructure.

Net profit after tax was $8.7 million compared to $5.7 million for

the six months to 31 December 2015, an increase of 52%.

This increase was due to additional sales volumes available from

our new sea farms and fair value gains associated with the

increase in biomass at sea compared to the same time a year

ago. For the six month period the total volume sold was 3,407

metric tonnes, which is 405 metric tonnes above sales for the prior

comparable period, an increase of 13%. The total biomass of fish

at sea was up by 22% on the same time a year ago, principally

due to the introduction of new sea farms.

DIRECTORS’ REPORT

FOLLOWING THE COMPLETION OF THE

SIX MONTH PERIOD TO 31 DECEMBER

2016 (1H17), THE BOARD IS PLEASED TO

CONFIRM A STRONG FINANCIAL RESULT,

SUPPORTED BY NEW ZEALAND KING

SALMON’S BRANDING AND MARKET

POSITIONING STRATEGY ALONGSIDE ON-

TARGET FISH PERFORMANCE. THE BOARD

AFFIRMS ITS FULL YEAR FY17 FORECAST AS

PRESENTED IN ITS PRODUCT DISCLOSURE

STATEMENT DATED 23 SEPTEMBER 2016.

Pro forma operating EBITDA was $7.3 million. Pro forma operating

results reverse out the impact of fair value gains, non-recurring

costs relating to New Zealand King Salmon’s IPO, the closing out of

redundant interest rate swaps, and costs incurred in relation to the

Ministry for Primary Industry’s consultation process for the possible

relocation of six Marlborough salmon farms.

The Board is pleased to advise that a fully imputed interim dividend

of 2.0 cents per share has been declared and will be paid on

24 March 2017.

BUSINESS UPDATE

Our premium branded strategy continues to drive demand in

excess of available supply. This underpins improvements in value as

well as generating stronger customer loyalty, as we experience a

significant increase in salmon production volumes.

During the period we made a number of positive steps towards

executing our strategy, including significant production and sales

developments.

Sales Developments

From a sales and marketing perspective, we have been actively

developing branded sales leads with current and new customers

to match expected production volumes over the medium term.

New channel development in existing markets has also been a

feature – for example, over the past six months we have added

retail and marketing expertise to our North American team to

support existing business but also to drive business development

in supermarket channels for the Regal brand. We also commenced

an Ōra King sales programme to China in partnership with China

Resources Ng Fung Ltd. Finally, we launched our premium

pet food brand Omega Plus in South Island supermarkets. Omega

Plus, whilst still in its early stages, intends to improve whole-of-fish

value for us by enabling us to convert by-products into high value

branded pet food products.

We consider that the strong growth in export volumes achieved,

which were up 19% on the prior comparable period, confirm the

receptiveness of the market to our premium branded

export strategy.

4

Production Developments
On the production side, salmon farming is now underway at all

three of our new sea farms, which all benefit from higher water

flow. During the period we had the inaugural harvest from two of

our three new farms, Waitata and Ngamahau. The final new farm,

Kopaua, is due for harvest later in 2018.

We have an ongoing program to improve the effectiveness

of our salmon aquaculture operations. For example, recent

improvements implemented at our hatcheries have resulted in

larger smolt being put to sea, with the objective of measurable

improvements in harvest size and quality. Another area of focus

is the improvement of feed performance across a diversified

range of feed suppliers. During the period we trialled feed from

new potential suppliers and are heading into peak summer with

summer diets from two key suppliers.

Early in 2017 we finalised the implementation of our new harvest

method utilising leading pump technology, which opens up

export opportunities to Europe whilst also driving anticipated

operational efficiencies.

Key fish performance metrics were in line with expectations for

the period, with feed conversion ratio (FCR) and mortality rate at

1.76x and 4.6% respectively.

Other Developments

The company continues to develop farming and environmental

management practices to optimise production and improve

environmental outcomes. In January 2017, the Minister for Primary

Industries commenced a consultation process on the proposal to

relocate up to six salmon farms from their historic locations (up to

30 years old) to more suitable higher water flow sites. The board

is supportive of this independent process. In our view a successful

outcome will generate significant positive environmental, social

and financial benefits for all stakeholders, including our Top of the

South community.

The board also welcomed Ms Wang Xin, Director of China

Resources Ng Fung Ltd, as a non-executive director of

New Zealand King Salmon. Ms Wang Xin joined the board in

February 2017. China Resources Ng Fung Ltd purchased

a 9.99% shareholding in New Zealand King Salmon as a part

of the recent IPO.

OUTLOOK

The outlook for New Zealand King Salmon is positive. In the near

term, the board has reaffirmed its full year FY17 forecast for a

pro forma operating EBITDA of $19.2 million, as presented in its

Product Disclosure Statement dated 23 September 2016.

The longer term outlook for the company is also positive with

strong demand building for our premium brands supported by

positive global food and health trends.

The board would like to acknowledge the contribution of our team

to New Zealand King Salmon’s ongoing success. A further update

will be provided to the market following the completion of the

peak summer period.

CORPORATE INFORMATION

DIRECTORS APPOINTMENT DATE

John William Dudley Ryder (Independent Chairman) 21 September 2016

Grantley Bruce Rosewarne (Chief Executive Officer)

21 September 2016

Mark Robert Hutton (Independent Director)

21 September 2016

Jack Lee Porus 21 September 2016

Paul James Steere (Independent Director)

21 September 2016

Thomas Chai Leng Song 21 September 2016

Wang Xin (Non-Executive Director)

28 February 2017

REGISTERED OFFICE

93 Beatty Street

Annesbrook

Nelson

New Zealand

PRINCIPAL PLACE

OF BUSINESS

93 Beatty Street

Annesbrook

Nelson

New Zealand

BANKERS

The Bank of New Zealand

81 Riccarton Road

Christchurch

New Zealand

ANZ Bank New Zealand Limited

248 Trafalgar Street

Nelson

New Zealand

SOLICITORS

Glaister Ennor

18 High Street

Auckland

New Zealand

AUDITORS

Ernst & Young (EY)

20 Twigger Street

Christchurch

New Zealand

John Ryder

CHAIRMAN

Grant Rosewarne

MANAGING DIRECTOR & CEO

5

INTERIM FINANCIAL REPORT

INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

Notes $000 $000



Revenue 5 63,626 56,598

Cost of goods sold (59,239) (51,068)

Fair value gain on biological transformation 28,722 16,548

Freight costs to market (6,077) (4,839)

Gross profit 27,032 17,239


Other operating income 738 664

Sales, marketing and advertising expenses (4,012) (3,005)

Distribution overheads (1,436) (968)

Corporate expenses (3,513) (2,783)

Other expenses (2,621) (4)

Earnings before interest, tax, depreciation and amortisation 16,188 11,143


Depreciation and amortisation expense (2,106) (2,024)

Finance income 86 38

Finance costs (1,572) (2,175)

Profit before tax 12,596 6,982


Income tax expense (3,891) (1,246)

Net profit for the period 8,705 5,736

Other comprehensive income

Other comprehensive income to be reclassified to profit or loss in

subsequent periods (net of tax):

Exchange differences on translation of foreign operations (28) (144)

Net movement on cash flow hedges 1,813 (564)

Other comprehensive income not to be reclassified to profit or loss in

subsequent periods (net of tax):

Share based payment expense 41 –

Net other comprehensive income/(loss) 1,826 (708)

Total comprehensive income for the period 10,531 5,028

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

Earnings per share

Basic profit for the period attributable to ordinary equity holders of the parent $0.07 $0.05

Diluted profit for the period attributable to ordinary equity holders of the parent $0.07 $0.05

Net tangible asset value per share

Net tangible asset value for the period attributable per ordinary share $1.08 $1.09

The above interim consolidated statement of comprehensive income should be read in conjunction with the accompanying notes.

6

INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

Foreign Share

Currency Based

Share Translation Hedge Payment Retained Total

Capital Reserve Reserve Reserve Earnings Equity

UNAUDITED $000 $000 $000 $000 $000 $000


As at 1 July 2016 25,296 (527) (2,195) - 14,440 37,014


Profit for the period - - - - 8,705 8,705

Other comprehensive loss - (28) 1,813 41 - 1,826


Total comprehensive income/(loss) for the period - (28) 1,813 41 8,705 10,531


Increase in share capital in preparation for IPO 68,915 - - - - 68,915

Shares issued 30,105 - - - - 30,105

Transaction costs arising on share issue (1,797) - - - - (1,797)

As at 31 December 2016 122,519 (555) (382) 41 23,145 144,768

UNAUDITED

$000 $000 $000 $000 $000 $000


As at 1 July 2015 25,296 (333) (27) - 11,847 36,783


Profit for the period - - - - 5,736 5,736

Other comprehensive income/(loss) - (144) (564) - - (708)


Total comprehensive income/(loss) for the period - (144) (564) - 5,736 5,028


As at 31 December 2015 25,296 (477) (591) - 17,583 41,811

The above interim consolidated statement of changes in equity should be read in conjunction with the accompanying notes.

7

INTERIM FINANCIAL REPORT

31 Dec 2016 30 Jun 2016
UNAUDITED AUDITED

Notes $000 $000

ASSETS

Current assets

Cash and cash equivalents 10,694 2,419

Trade and other receivables 15,210 10,229

Inventories 7 19,244 17,291

Biological assets 8 58,464 45,537

Income tax receivable 173 –

Non-current assets held for sale 421 421

Other financial assets 13 – 2,758

Derivative financial assets 832 526

Total current assets 105,038 79,181

Non-current assets

Property, plant and equipment 34,294 32,596

Biological assets 8 8,828 7,413

Derivative financial assets 1,985 1,443

Intangible assets 3,800 3,868

Deferred tax asset 1,527 1,967

Goodwill 39,255 39,255

Total non-current assets 89,689 86,542

TOTAL ASSETS 194,727 165,723


LIABILITIES

Current liabilities

Interest-bearing loans and borrowings 9 1,239 19,326

Trade and other payables 21,424 15,416

Income tax payable – 580

Employee benefits 2,481 2,384

Other financial liabilities – 4,427

Shareholder loans – 73,114

Derivative financial liabilities 1,820 2,319

Total current liabilities 26,964 117,566

Non-current liabilities

Interest-bearing loans and borrowings 9 10,140 163

Employee benefits 434 465

Deferred tax liabilities 10,913 7,740

Derivative financial liabilities 1,508 2,775

Total non-current liabilities 22,995 11,143

TOTAL LIABILITIES

49,959 128,709

NET ASSETS

144,768 37,014


EQUITY

Equity attributed to equity holders of the company

Share capital 12 122,519 25,296

Reserves (896) (2,722)

Retained earnings 23,145 14,440

TOTAL EQUITY 144,768 37,014

INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2016

For and on behalf of the Board, who authorised the issue of these interim financial statements on 28 February 2017.

Paul Steere 28 February 2017

DIRECTOR AND AUDIT & RISK COMMITTEE CHAIRMAN

John Ryder 28 February 2017

CHAIRMAN

The above interim consolidated statement of financial position should be read in conjunction with the accompanying notes.

8

INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

$000 $000

OPERATING ACTIVITIES

Receipts from customers 59,744 52,368

Payments to suppliers (43,033) (37,925)

Payments to employees (15,189) (13,158)

Interest received 78 40

Interest paid (1,052) (679)

Insurance income 214 530

Income tax paid (1,741) (513)

Net cash flows from/(used in) operating activities (979) 663

INVESTING ACTIVITIES

Proceeds from sale of property, plant and equipment 10 31

Purchase of property, plant and equipment (3,696) (3,073)

Purchase of intangible assets (49) (30)

Net cash flows used in investing activities (3,735) (3,072)

FINANCING ACTIVITIES

Revolving loan repaid (9,000) -

Gross proceeds from share issue 30,105 -

Transaction cost arising on share issue (1,797) -

Proceeds from shareholder advances 1,402 500

Repayment of shareholder advances (7,651) -

Payment of finance lease liabilities (70) (40)

Net cash flows from financing activities 12,989 460

Net increase/(decrease) in cash and cash equivalents 8,275 (1,949)

Cash and cash equivalents at 1 July 2,419 5,522

Cash and cash equivalents at 31 December 10,694 3,573

The above interim consolidated statement of cash flows should be read in conjunction with the accompanying notes.

9

INTERIM FINANCIAL REPORT

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

1. CORPORATE INFORMATION

The interim financial statements of New Zealand King Salmon Investments Limited (the Company) and its subsidiaries (together

the Group) for the six months ended 31 December 2016 were authorised by the directors on 28 February 2017.

New Zealand King Salmon Investments Limited is a company incorporated and domiciled in New Zealand. The Company is

registered under the Companies Act 1993 and listed on the NZX Main Board ("NZX") and the Australian Securities Exchange ("ASX").

The Company is an FMC reporting entity under the Financial Markets Conduct Act 2013 and the Financial Reporting Act 2013.

The interim consolidated financial statements are for the six months ended 31 December 2016 and have been prepared in

accordance with NZ GAAP. New Zealand King Salmon Investments Limited is a profit-orientated entity.

The Group is principally engaged in the farming, processing and sale of premium salmon products.

2. PREPARATION OF INTERIM FINANCIAL STATEMENTS

a. Statement of compliance

The interim consolidated financial statements for the six months ended 31 December 2016 have been prepared in accordance with

NZ IAS 34 - Interim Financial Reporting and IAS 34 Interim Financial Reporting, and should be read in conjunction with the annual

financial statements as at 30 June 2016 which were prepared in accordance with NZ IFRS and IFRS.

The interim consolidated financial statements for the six months ended 31 December 2016 are unaudited. Comparative information

for the interim consolidated statement of financial position is at 30 June 2016 and is audited. Comparative information for the

interim consolidated statement of comprehensive income, interim consolidated changes in equity and interim consolidated

statement of cash flows is for the comparative six month period and is unaudited.

b. Basis of measurement

The accounting policies adopted in the interim financial statements are consistent with those applied in the annual financial

statements as at 30 June 2016.

c. Significant accounting judgements, estimates and assumptions

Management have applied the same principles and used the same key sources of estimation in the preparation of the interim

financial statements as those applied to in the consolidated financial statements for the year ended 30 June 2016.

3. SIGNIFICANT CHANGES IN THE CURRENT REPORTING PERIOD

The financial position of the Group was affected by the following significant events and transactions during the reporting period:-

a. Initial Public Offer (IPO)

On 19 October 2016, the Company listed on the NZX Main Board ("NZX") and Australian Securities Exchange ("ASX"). The listing

resulted in a primary issue of 26,785,715 shares and with an additional 1,180,747 shares issued to senior executives and employees.

Proceeds of $30 million were raised in accordance with the Product Disclosure Statement dated 23 September 2016.

b. Capital Structure

Prior to the IPO shareholder loans were converted to shares, amended banking arrangements were put in place and with the

proceeds from the IPO bank borrowings were reduced to $10 million.

4. SEASONALITY

The Group's business is not considered to be highly seasonal. Sales and related costs vary from month to month with overall

variation considered to be immaterial. The cost of fish has historically shown seasonal variation between the first and second halves

of the financial year due to harvesting from farms with different cost structures. Management has concluded that variations are not

'highly seasonal' in accordance with IAS 34 as this is dependent on operational planning. In any given year the Group would expect

to harvest fish from all active sea farms.

10

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

5. SEGMENT INFORMATION

a. Segment results

For management purposes, the Group is organised into three business units based on geographical sales market and customer

channel. The operating results of the business units are monitored for the purpose of making decisions about resource allocation

and performance assessment.

The Group's reportable segments are:

New Zealand Retail

The company provides these customers with pre-packed value added products (including wood

roasted and cold smoked product), whole fresh fish and pre-cut fillets.

New Zealand Foodservice The company provides these customers with a broad variety of salmon products including whole

fresh fish, pre-cut fillets, portions and a range of smoked products.

Export Market Predominantly customers based outside New Zealand, most of whom currently fall into the

Foodservice category as described above.

Segment performance is evaluated at the EBITDA level and results are as follows:

New Zealand New Zealand Export

Retail Foodservice Market Total

UNAUDITED $000 $000 $000 $000

Six months ended 31 December 2016

Revenue 17,136 19,490 27,000 63,626

Segment results (EBITDA) 3,944 5,231 7,012 16,188

UNAUDITED $000 $000 $000 $000

Six months ended 31 December 2015

Revenue 14,717 18,510 23,371 56,598

Segment results (EBITDA) 2,421 3,249 5,473 11,143

Depreciation, amortisation, finance income, finance cost and fair value gains and losses on financial assets are not allocated to

individual segments as the underlying instruments are managed on a group basis.

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

Segment results reconcile to profit before tax as follows: $000 $000

Segment results 16,188 11,143

Depreciation, amortisation and impairment (2,106) (2,024)

Finance costs (1,486) (2,137)

Group profit before tax 12,596 6,982


The Group does not prepare information allocating assets and liabilities to the market facing segments as all material assets and

liabilities are managed on a group basis.

b. Revenue by geographical location of customers

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

$000 $000

New Zealand 36,626 33,228

North America 14,229 12,223

Australia 6,249 4,688

Japan 2,687 2,641

Europe 946 930

Other 2,889 2,888

63,626 56,598


Sales net of settlement discounts to one major customer for the period ended 31 December 2016 accounted for over 10% of total

revenue. Sales to that customer totalled $8,516k or 13% of total sales (31 December 2015: one customer accounted for $5,593k or

10% of total sales and another for $7,136k or 13% of total sales). In both years these customers were included in the New Zealand

Retail segment.

11

INTERIM FINANCIAL REPORT

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

6. EARNINGS PER SHARE

Earnings per share is calculated by dividing the profit for the period attributable to shareholders by the weighted average number of

ordinary shares on issue during the period.

Diluted earnings per share assume conversion of all potential ordinary shares in determining the weighted average number of

ordinary shares on issue.

The Company completed a 2:11 for 1 share split on 19 September 2016. On 19 October 2016 the Company issued 27,966,462 shares in

the initial public offering. The weighted average number of ordinary shares used in the calculation of earnings per share, basic and

diluted, for 2015 has been adjusted to reflect the share split.

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

$000 $000

Profit attributable to ordinary equity holders of the parent for basic and diluted earnings 8,705 5,736


Shares Shares

000 000

Weighted average number of ordinary shares for basic earnings per share 121,439 110,191

Share options - 375

Weighted average number of ordinary shares for diluted earnings per share 121,439 110,566


7. INVENTORIES

31 Dec 2016 30 June 2016

UNAUDITED AUDITED

$000 $000

Raw materials 11,286 9,811

Work in progress 111 50

Finished goods 7,847 7,430

Total inventories 19,244 17,291

The closing cost of finished goods as at 31 December 2016 includes a fair value uplift at point of harvest of $2,212k (June 2016:

$2,507k) and an impairment provision of $972k (June 2016: $1,572k).

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

$000 $000

Amount of inventories recognised as an expense in the statement of comprehensive income

Cost of inventories recognised as an expense 59,596 50,749

Movement in net realisable value of inventory (increase)/decrease (357) 319

Total cost of inventories included in cost of goods sold 59,239 51,068

The cost of inventories recognised as an expense for the period ended 31 December 2016 includes a fair value uplift at point of

harvest of $17,688k (December 2015: $14,625k).

12

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

8. BIOLOGICAL ASSETS

The Group has three hatcheries in the South Island and eight operational marine salmon farms in the Marlborough Sounds. The fish

livestock typically grow for up to 31 months before harvest.

31 Dec 2016 30 Jun 2016

UNAUDITED AUDITED

Fair value Fair value

$000 $000

Biological assets:

As at 1 July 52,950 47,595

Increase due to biological transformation 62,519 91,530

Decrease due to harvest /mortality (48,907) (86,754)

Changes in fair value 730 579

As at 31 December 2016 and 30 June 2016 67,292 52,950

Closing fair value uplift from cost on biological assets 27,932 16,602


Fair value gain/(loss) recognised in profit or loss

Gain arising from growth of biological assets 27,992 29,644

Movement in fair value of biological assets 730 579

Total fair value gain/(loss) on biological transformation 28,722 30,223

kg 000 kg 000

Closing fresh water stocks 178 174

Closing sea water stocks 5,973 4,400

Total closing biomass (live weight) at 31 December 2016 and 30 June 2016 6,151 4,574


31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

Biomass (live weight) kg 000 kg 000

Fish harvest for the period 3,861 3,392

Fair value measurement

Measurement of fair value is performed using a fair value model. The method of valuation therefore falls into level 3 of the fair value

hierarchy as the inputs are unobservable inputs.

Selling price is estimated at balance dated based on the most relevant future market price at expected harvest date. The valuation

of biological assets is carried out separately for each site at a brood and strategy level. Estimated actual cost up to the date

of harvest per site is used to measure the expected margin at the time the fish is defined as ready for harvest, being 4.0kg live

weight. The expected margin is recognised proportionately based on average biomass at reporting date. Fair value measurement

commences at the date of transfer to sea water as this is considered the point at which the fish commence their grow out cycle.

Fair value risk and sensitivity

The Group is exposed to financial risks relating to the production of salmon stocks including climatic events, disease and

contamination of water space.

The Group seeks to produce and market the highest quality salmon products. Extensive monitoring and benchmarking is carried

out to provide optimum conditions and diets to maximise fish performance during the grow out cycle. Sales are maintained in a

range of brands, products and markets to maximise returns from the quality mix of fish harvested. The Group has insurance to cover

various risks relating to the livestock.

The estimate of unrealised fair value uplift from cost is based on several assumptions. Changes in these assumptions will impact the

fair value calculation. The realised profit which is achieved on the sale of inventory will differ from the calculations of fair value of

biological assets because of changes in key factors such as the final market destinations of inventory sold, changes in price, foreign

exchange rates, harvest weight, growth rates, mortality, cost levels and differences in harvested fish quality.

Leaving all other variables constant a 5.0% increase/decrease in average sales prices would increase/decrease the fair value of

biological assets and profit before tax by $4.6m, while a 5.0% increase/decrease in harvest volume would increase/decrease the fair

value of biological assets and profit before tax by $1.4m.

A change in production costs will generally have a lesser impact on the fair value of biological assets than the same percentage

change in sale price or harvest volumes. Changes in fish health and environmental factors may affect the quality of harvested fish,

which may be reflected in realised profit via both achieved sales price and production costs.

13

INTERIM FINANCIAL REPORT

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

9. INTEREST BEARING LOANS AND BORROWINGS

31 Dec 2016 30 Jun 2016

UNAUDITED AUDITED

$000 $000

Current

Current portion of finance lease liabilities 156 66

Current portion of secured bank loans - 19,000

Other borrowings 1,083 260

1,239 19,326

Non-current

Finance lease liabilities 140 163

Secured bank loans 10,000 -

10,140 163

The Company has facilities with BNZ for $30m, secured by a general security deed over the assets of the Group. The expiry date of

facility A of $18m is 25 November 2020, and facility B of $12m expires on 18 October 2019. At balance date $10m of facility A was

drawn (June 2016: $19m).

10. FAIR VALUES OF FINANCIAL INSTRUMENTS

The table below is a comparison by class of the carrying amounts and fair value of the Group’s financial instruments, other than

those with carrying amounts that are reasonable approximations of fair values:

31 Dec 2016 30 Jun 2016

Carrying Fair Carrying Fair

amount value amount value

UNAUDITED UNAUDITED AUDITED AUDITED

$000 $000 $000 $000

FINANCIAL ASSETS

Current assets

Forward exchange contracts 635 635 339 339

Foreign exchange options 197 197 187 187

Loans to employees - - 2,758 2,758

832 832 3,284 3,284

Non-current assets

Forward exchange contracts 1,002 1,002 734 734

Foreign exchange options 983 983 709 709

1,985 1,985 1,443 1,443

FINANCIAL LIABILITIES


Current liabilities

Loans and borrowings 1,083 1,083 19,000 19,000

Obligations under finance leases 156 156 66 66

Forward exchange contracts 1,077 1,077 1,107 1,107

Foreign exchange options 60 60 27 27

Interest rate swaps 683 683 1,185 1,185

Other financial liabilities - - 4,427 4,427

Shareholder loans - - 73,114 73,114

3,059 3,059 98,926 98,926

Non-current liabilities

Loans and borrowings 10,000 10,000 - -

Obligations under finance leases 140 134 163 149

Forward exchange contracts 915 915 1,319 1,319

Foreign exchange options 462 462 634 634

Interest rate swaps 131 131 822 822

11,648 11,642 2,938 2,924


The carrying value of cash and short term deposits, trade receivables, trade payables and other current liabilities is equivalent to

their fair value due to the short term maturities of these instruments.

14

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

10. FAIR VALUES OF FINANCIAL INSTRUMENTS (CONTINUED)

Valuation methods

Financial instruments have been categorised into the following hierarchy and valued according to the following definitions, based on

the lowest level input that is significant to the fair value measurement as a whole:

Level 1: Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly (i.e. as

prices) or indirectly (i.e. derived from prices)

Level 3: Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs)

All derivative financial instruments for which a fair value is recognised have been categorised within level 2 of the fair value

hierarchy. Industry experts have provided the fair values for all derivatives based on an industry standard model.

11. COMMITMENTS AND CONTINGENCIES

a. Capital expenditure and other commitments

31 Dec 2016 30 Jun 2016

UNAUDITED AUDITED

$000 $000

Total capital and other commitments 1,946 2,602


The Group has entered into agreements to purchase aquaculture plant and equipment and processing plant and equipment. As at

31 December 2016 the total commitment is $1,946k (June 2016: $508k).

b. Contingencies

The Group has a contingent liability of $783k in respect of a fish transport contract requiring the Group to purchase three bulk

tankers, should the fish transport contract be terminated early (June 2016: $840k).

The Group is currently in discussion with a feed supplier regarding a feed quality issue and the outcome is yet to be resolved.

15

INTERIM FINANCIAL REPORT

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

12. CAPITAL AND RESERVES

31 Dec 2016 30 Jun 2016

UNAUDITED AUDITED

000 000

Issued Capital 138,158 25,268


Issued capital at 31 December 2016 amounted to $122,517,958 (June 2016: $25,295,501) and 138,157,843 (June 2016: 25,267,695)

ordinary shares.

a. Ordinary share capital

Ordinary shares

Ordinary shares are fully paid with no par value. Each ordinary share has an equal right to vote, to participate in dividends, and to

share in any surplus on the winding up of the Company.

31 Dec 2016 30 Jun 2016

UNAUDITED AUDITED

# shares Value # shares Value

000 $000 000 $000

b. Movement in ordinary share capital

As at 1 July 2015 25,295 25,296 25,268 25,296

Shareholder loans converted to share capital 26,941 70,202

Shares issued by way of 2.11 to 1 share split 57,955 - - -

Issue of new shares pursuant to IPO 26,786 30,000 - -

Less: Transactional costs arising on share issue - (1,797) - -

Employee offer pursuant to IPO 1,181 1,323 - -

Share issue for employee share scheme - (2,505) - -

138,158 122,519 25,268 25,296


In preparation for the IPO, shareholder loans of $70,202,480 were converted to shares with one share issued for each $2.6058 of

shareholder loan converted. In September 2016 the ordinary share capital that had been converted from shareholder loans was

subdivided on the basis of a 2.11 to 1 share split which resulted in an additional 57,955,025 shares being issued on 19 September 2016.

The Company issued 26,785,715 of ordinary shares at $1.12 per share at the IPO on 19 October 2016.

The Senior Executive Share Scheme involves the Company making interest-free loans to selected senior executives to acquire shares

in the Company. 5,063,406 shares are held by a custodian at the end of the reporting period.

c. Foreign currency translation reserve

The foreign currency translation reserve is used to record exchange differences arising from the translation of the financial

statements of the foreign subsidiary.

13. RELATED PARTY DISCLOSURES

a. Subsidiaries

New Zealand King Salmon Investments Limited has the following trading subsidiaries.

Country of

incorporation Equity interest

Name 31 Dec 2016 30 Jun 2016

The New Zealand King Salmon Co Limited New Zealand 100% 100%

The New Zealand King Salmon Pty Limited Australia 100% 100%


The principal activity of The New Zealand King Salmon Co Ltd is the farming and processing of salmon. The activity of The New

Zealand King Salmon Pty Ltd is the distribution of salmon.

b. Entities with significant influence over the Group

At balance date Oregon Group Limited owned 40.26% (30 June 2016: 50.88%) of the shares in New Zealand King Salmon

Investments Limited.

16

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2016

13. RELATED PARTY DISCLOSURES (CONTINUED)

c. Transactions with related parties

The following provides the total amount of transactions that were entered into with related parties for the relevant financial year.

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

$000 $000

Interest paid - Oregon Group Limited 272 787

Interest paid - other shareholders 194 619

Goods and services purchased from other related parties 1 52


d. Terms and conditions of transactions with related parties

Sales to and purchases from related parties are made in arm’s length transactions both at normal market prices and on normal

commercial terms.

e. Amounts owing to related parties

31 Dec 2016 30 Jun 2016

UNAUDITED AUDITED

$000 $000

Current:

Amounts advanced by shareholders of NZKS Custodian Ltd - 4,427

Shareholders’ loans - 53,826

Shareholder advance repayable on demand - 15,765

Current portion of shareholder loans - 69,591

Accrued interest on shareholders’ loans - 3,523

- 73,114

On 19 September 2016 shareholder loans of $70,202,480 were converted to shares with one share issued for each $2.6058 of

shareholder loan converted.

f. Amounts owing by related parties

31 Dec 2016 30 Jun 2016

UNAUDITED AUDITED

$000 $000

Owing by related parties - 2,758


These loans are interest free and are in relation to the Senior Executive Share Scheme.

g. Compensation of key management personnel of the Group

31 Dec 2016 31 Dec 2015

UNAUDITED UNAUDITED

$000 $000

Short-term employee benefits 1,390 1,017

Post employment pension and medical benefits 55 45

1,445 1,062


14. EVENTS AFTER BALANCE DATE

There have been no significant events after balance date.

17

INTERIM FINANCIAL REPORT

REVIEW REPORT
18

93 Beatty Street, Annesbrook
Nelson, New Zealand

www.kingsalmon.co.nz

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.